Genmab — November 2016
-
Mon ikke JNJ kan være tæt på at lukke Actelion handelen. Det betyder, at de ikke tager initiativ til at købe Genmab lige foreløbig. Men Actelion aktionærerne kan vel hurtigt finde et sted at sætte pengene til at yngle videre - f.eks. i Europas største biotech (hvis Actelion købes af JNJ) med en lysende fremtid.
-
Det er åbenbart kotyme nogle steder at fordele 1. dara-infusion over 2 dage. Kan måske mildne bivirkninger. http://central.hoparx.org/communities/community-home/digestviewer/viewthread?GroupId=13&MessageKey=772ec7f9-47a9-4fd4-abaa-72573226afc2&CommunityKey=879874b2-4c5b-4fde-9547-4176be27b4e3&tab=digestviewer#bm0
-
-
ved ikke lige hvad der gik galt med det link, det var det forkerte.https://finance.yahoo.com/news/why-genmab-gnmsf-could-shock-163104770.html
-
29/11 17:02
af paundal
1285 faktisk
29/11 17:01
af Repsac
En overgang var auktionen i 1270. -
29/11 17:02
af paundal
1285 faktisk
-
God morgen.

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind